Company intelligence / Profile preview

Eimeria

Benito Juárez, Ciudad de México, Mexico

Ownership: Private
Development stage: Other

Overview

Eimeria S.A. de C.V. is a commercial-stage veterinary biotechnology company that develops and manufactures biological products for animal health. Its primary product is the Autocox vaccine, a live oocyst-based immunizer designed to prevent coccidiosis in poultry by targeting several species of the Eimeria parasite.

Therapeutic areas: Infectious Diseases
Modalities: Vaccine
Industry: Veterinary

Partnerships

SAGARPA (Certification)

Beyond the preview

Go deeper on Eimeria.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eimeria.

Explore the full profile